Novo Nordisk A/S NVO
NYSE
Recommendation
Dividend Power Score
Day's Range
$40.64$41.80
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.64B | 18.20B | 18.96B | 15.45B | 15.30B |
| Total Depreciation and Amortization | 2.15B | 2.18B | 2.19B | 2.17B | 1.99B |
| Total Amortization of Deferred Charges | 49.57M | 49.57M | 49.57M | 49.57M | 36.44M |
| Total Other Non-Cash Items | -111.34M | -1.96B | -4.10B | -3.89B | -1.73B |
| Change in Net Operating Assets | 247.61M | 2.33B | 1.46B | 4.49B | 3.26B |
| Cash from Operations | 19.97B | 20.80B | 18.56B | 18.28B | 18.85B |
| Capital Expenditure | -8.65B | -8.75B | -9.01B | -9.13B | -8.56B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -142.90K |
| Cash Acquisitions | 156.49M | 156.49M | 156.49M | 156.49M | -11.65B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.32B | -4.29B | -4.20B | -3.08B | 1.78B |
| Cash from Investing | -12.82B | -12.89B | -13.05B | -12.06B | -18.42B |
| Total Debt Issued | 65.90B | 66.08B | 92.55B | 103.93B | 118.07B |
| Total Debt Repaid | -34.87B | -29.64B | -68.39B | -79.19B | -78.47B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -10.00B | -5.90B | -2.40B | -1.39B | -8.88B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.08B | -8.14B | -8.14B | -7.59B | -7.59B |
| Other Financing Activities | -3.25B | -3.06B | -22.66B | -2.25B | -2.25B |
| Cash from Financing | -5.28B | -3.84B | -8.06B | -4.68B | -4.01B |
| Foreign Exchange rate Adjustments | -6.14M | -8.74M | -140.05M | -108.95M | -23.01M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.87B | 4.06B | -2.69B | 1.43B | -3.61B |